KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Edwards Lifesciences (EW) Construction in Progress (2023 - 2025)

Edwards Lifesciences has reported Construction in Progress over the past 3 years, most recently at $301.2 million for Q4 2025.

  • Quarterly results put Construction in Progress at $301.2 million for Q4 2025, up 23.44% from a year ago — trailing twelve months through Dec 2025 was $301.2 million (up 23.44% YoY), and the annual figure for FY2025 was $301.2 million, up 23.44%.
  • Construction in Progress for Q4 2025 was $301.2 million at Edwards Lifesciences, up from $244.0 million in the prior quarter.
  • Over the last five years, Construction in Progress for EW hit a ceiling of $301.2 million in Q4 2025 and a floor of $244.0 million in Q4 2024.
  • Median Construction in Progress over the past 3 years was $292.5 million (2023), compared with a mean of $279.2 million.
  • Biggest five-year swings in Construction in Progress: decreased 16.58% in 2024 and later grew 23.44% in 2025.
  • Edwards Lifesciences' Construction in Progress stood at $292.5 million in 2023, then decreased by 16.58% to $244.0 million in 2024, then grew by 23.44% to $301.2 million in 2025.
  • The last three reported values for Construction in Progress were $301.2 million (Q4 2025), $244.0 million (Q4 2024), and $292.5 million (Q4 2023) per Business Quant data.